Full Text
PCV84 Resource Utilization and Costs for Candesartan in Heart Failure- Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting

Abstract

Authors

F.M. Fruhwald A.D. Vavrovsky

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×